id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2013-N-0579-0005,FDA,FDA-2013-N-0579,"Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Biological Products: Reporting of Biological Product Deviations and Human Cells, Tissues, and Cellular and Tissue-Based Deviations in Manufacturing",Notice,30 Day Proposed Information Collection,2016-11-14T05:00:00Z,2016,11,2016-11-14T05:00:00Z,2016-12-15T04:59:59Z,2016-11-14T18:27:00Z,2016-27259,0,0,09000064823935bf
FDA-2013-N-0579-0003,FDA,FDA-2013-N-0579,"Agency Information Collection Activities; Proposed Collection; Comment Request; Biological Products: Reporting of Biological Product Deviations and Human Cells, Tissues, and Cellular and Tissue-Based Deviations in Manufacturing; Forms FDA 3486 and 3486A",Notice,60 Day Proposed Information Collection,2016-06-07T04:00:00Z,2016,6,2016-06-07T04:00:00Z,2016-08-09T03:59:59Z,2016-08-09T01:00:14Z,2016-13366,0,0,0900006482018b27